BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 549632)

  • 1. Membrane components in the red cells of patients with sickle cell anemia. Relationship to cell aging and to irreversibility of sickling.
    Westerman MP; Diloy-Puray M; Streczyn M
    Biochim Biophys Acta; 1979 Oct; 557(1):149-55. PubMed ID: 549632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte membrane lipid reorganization during the sickling process.
    Chiu D; Lubin B; Shohet SB
    Br J Haematol; 1979 Feb; 41(2):223-34. PubMed ID: 427032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell [14C]cholesterol exchange and plasma cholesterol esterifying activity of normal and sickle cell blood.
    Jain SK; Shohet SB
    Biochim Biophys Acta; 1982 May; 688(1):11-5. PubMed ID: 7093267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of irreversibly sickled cells in reducing the osmotic fragility of red cells in sickle cell anemia.
    Figueiredo MS; Zago MA
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):49-56. PubMed ID: 2932889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organizational differences in the membrane proteins of normal and irreversibly sickled erythrocytes.
    Rubin RW; Milikowski C; Wise GE
    Biochim Biophys Acta; 1980; 595(1):1-8. PubMed ID: 7349873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities in membrane phospholipid organization in sickled erythrocytes.
    Lubin B; Chiu D; Bastacky J; Roelofsen B; Van Deenen LL
    J Clin Invest; 1981 Jun; 67(6):1643-9. PubMed ID: 7240412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Ca2+-dependent biochemical changes in the ageing process in normal red cells and in the development of irreversibly sickled cells.
    Allan D; Raval PJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):499-503. PubMed ID: 2446988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialic acid in sickle cell disease.
    Ekeke GI; Ibeh GO
    Clin Chem; 1988 Jul; 34(7):1443-6. PubMed ID: 3390914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-bound autologous immunoglobulin in erythrocyte subpopulations from patients with sickle cell disease.
    Green GA; Rehn MM; Kalra VK
    Blood; 1985 May; 65(5):1127-33. PubMed ID: 3888304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes.
    Schwartz RS; Tanaka Y; Fidler IJ; Chiu DT; Lubin B; Schroit AJ
    J Clin Invest; 1985 Jun; 75(6):1965-72. PubMed ID: 4008648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvesicles from sickle erythrocytes and their relation to irreversible sickling.
    Allan D; Limbrick AR; Thomas P; Westerman MP
    Br J Haematol; 1981 Mar; 47(3):383-90. PubMed ID: 6779851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of red cell membrane organization in sickle cell anaemia.
    Choe HR; Schlegel RA; Rubin E; Williamson P; Westerman MP
    Br J Haematol; 1986 Aug; 63(4):761-73. PubMed ID: 3730297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of valinomycin, A23187 and repetitive sickling on irreversible sickle cell formation.
    Westerman MP; Allan D
    Br J Haematol; 1983 Mar; 53(3):399-409. PubMed ID: 6402002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The irreversibly sickled cell.
    Smith CM; Krivit W; White JG
    Am J Pediatr Hematol Oncol; 1982; 4(3):307-15. PubMed ID: 7149169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane phospholipid abnormalities in pathologic erythrocytes: a model for cell aging.
    Wagner G; Chiu DT; Schwartz RS; Lubin B
    Prog Clin Biol Res; 1985; 195():237-50. PubMed ID: 4059270
    [No Abstract]   [Full Text] [Related]  

  • 16. Sickling of sickle erythrocytes does not alter phospholipid asymmetry.
    Raval PJ; Allan D
    Biochem J; 1984 Oct; 223(2):555-7. PubMed ID: 6497863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversibly sickled cells and red cell survival in sickle cell anemia: a study with both DF32P and 51CR.
    McCurdy PR; Sherman AS
    Am J Med; 1978 Feb; 64(2):253-8. PubMed ID: 629275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in membrane polypeptides, polyphosphoinositides and phosphatidate in dense fractions of sickle cells.
    Raval PJ; Allan D
    Biochim Biophys Acta; 1986 Apr; 856(3):595-601. PubMed ID: 3008837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells.
    Franck PF; Bevers EM; Lubin BH; Comfurius P; Chiu DT; Op den Kamp JA; Zwaal RF; van Deenen LL; Roelofsen B
    J Clin Invest; 1985 Jan; 75(1):183-90. PubMed ID: 3965502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte sialic acid in human sickle-cell disease.
    Onyemelukwe GC; Esievo KA; Kwanashie CN; Kulkarni AG; Obinechie EN
    J Comp Pathol; 1987 Mar; 97(2):143-7. PubMed ID: 3597847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.